CHE Chemed PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: CHE
- PE Ratio
The PE ratio for Chemed stock stands at 22.44 as of Jul 29, 2025. The calculation is based on the latest EPS of $20.71 and the stock price of $464.69 per share. A decrease of 21% has been observed in the PE ratio compared to its average of 28.3 of the last four quarters.
CHE PE ratio history
Over the last ten years, the average PE ratio of Chemed has been 28.87. The current 22.44 P/E ratio is 22% lower than the historical average. Looking back at the last ten years, CHE's PE ratio peaked in the Jun 2017 quarter at 49.52, with a price of $204.53 and an EPS of $4.13. The Sep 2015 quarter marked the lowest point at 20.47, with a price of $133.47 and an EPS of $6.52.
Chemed PE ratio by year
Maximum annual increase: 64.61% in 2017
Maximum annual decrease: -44.36% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 26.36 | -18.36% | $529.8 | $20.1 |
| 2023 | 32.29 | 5.76% | $584.75 | $18.11 |
| 2022 | 30.53 | -1.1% | $510.43 | $16.72 |
| 2021 | 30.87 | 16.05% | $529.04 | $17.14 |
| 2020 | 26.6 | -16.61% | $532.61 | $20.02 |
| 2019 | 31.9 | 44.15% | $439.26 | $13.77 |
| 2018 | 22.13 | -44.36% | $283.28 | $12.8 |
| 2017 | 39.77 | 64.61% | $243.02 | $6.11 |
| 2016 | 24.16 | 5.46% | $160.41 | $6.64 |
| 2015 | 22.91 | 25.53% | $149.8 | $6.54 |
| 2014 | 18.25 | 1% | $105.67 | $5.79 |
| 2013 | 18.07 | 24.36% | $76.62 | $4.24 |
| 2012 | 14.53 | 18.9% | $68.59 | $4.72 |
| 2011 | 12.22 | -30.33% | $51.21 | $4.19 |
| 2010 | 17.54 | 20.3% | $63.51 | $3.62 |
Chemed PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 29.71 | 12.71% | $615.32 | $20.71 |
| Dec 2024 | 26.36 | -12.22% | $529.8 | $20.1 |
| Sep 2024 | 30.03 | 10.36% | $600.97 | $20.01 |
| Jun 2024 | 27.21 | -20.39% | $542.58 | $19.94 |
| Mar 2024 | 34.18 | 5.85% | $641.93 | $18.78 |
| Dec 2023 | 32.29 | 1.29% | $584.75 | $18.11 |
| Sep 2023 | 31.88 | -10.83% | $519.7 | $16.3 |
| Jun 2023 | 35.75 | 6.78% | $541.67 | $15.15 |
| Mar 2023 | 33.48 | 9.66% | $537.75 | $16.06 |
| Dec 2022 | 30.53 | 21.83% | $510.43 | $16.72 |
| Sep 2022 | 25.06 | -2.72% | $436.56 | $17.42 |
| Jun 2022 | 25.76 | -11.81% | $469.39 | $18.22 |
| Mar 2022 | 29.21 | -5.38% | $506.55 | $17.34 |
| Dec 2021 | 30.87 | 28.68% | $529.04 | $17.14 |
| Sep 2021 | 23.99 | -3.85% | $465.12 | $19.39 |
CHE Price vs fair value
CHE average PE ratio chart
CHE's current PE ratio is lower than its 3, 5 and 10-year averages.
CHE PE vs peers
In comparison to its peers BCPC and SXT, CHE's PE ratio is lower, but it is higher than RPM's. Chemed is currently trading at a lower PE ratio (22.44) than its peers average of 32.65.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CHE Chemed Corp | 20.46 | $6.2B |
| RPM Rpm International Inc | 22.16 | $15.3B |
| AMED Amedisys Inc | 35.75 | $3.23B |
| BCPC Balchem Corp | 35.93 | $4.93B |
| SXT Sensient Technologies Corp | 36.73 | $4.76B |
Frequently asked questions
What is Chemed's PE ratio?
As of Jul 29, 2025, CHE stock has a price to earnings ratio of 22.44.
What is the 3-year average PE ratio for Chemed (CHE)?
As an average over the last 3 years, CHE stock has a PE ratio of 30.59.
What is the 5-year average PE ratio for Chemed (CHE)?
As an average over the last 5 years, CHE stock has a PE ratio of 28.86.
What is the highest PE ratio for CHE?
Over the last ten years, the quarterly PE ratio reached its highest level at 49.52 in the Jun 2017 quarter.
How does the current PE ratio for CHE compare to its historical average?
CHE's current price to earnings ratio is 22% below its 10-year historical average.
How is CHE's PE ratio calculated (Chemed PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 29, 2025), Chemed's share price is $464.69. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $20.71. Therefore, Chemed's PE ratio for today is 22.44. PE RATIO(22.44) = STOCK PRICE($464.69) / TTM EPS($20.71)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.